Table 8 ANOVA table of in-vitro drug release
From: Optimization of simvastatin transdermal patch for hyperlipidemia treatment in rat model
Source | Sum of Squares | df | Mean Square | F-value | p-value | |
|---|---|---|---|---|---|---|
Model | 228.65 | 3 | 76.22 | 4.76 | 0.0230 | Significant |
A-HPMC K100 | 28.01 | 1 | 28.01 | 1.75 | 0.2127 | |
B-ERL 100 | 10.22 | 1 | 10.22 | 0.6381 | 0.4413 | |
C-PEG | 190.42 | 1 | 190.42 | 11.89 | 0.0054 | |
Residual | 176.10 | 11 | 16.01 | |||
Lack of Fit | 144.20 | 9 | 16.02 | 1.00 | 0.5932 | Not significant |
Pure Error | 31.90 | 2 | 15.95 | |||
Cor Total | 404.74 | 14 |